IMS Health and healthcare consultancy Quintiles are planning to merge in an all-stock transaction which will value the combined company – Quintiles IMS Holdings – at $17.6 billion. Combined 2015 revenue for the two firms was around $7.2 billion.
Ari Bousbib and Tom PikeThe deal will create one of the world’s largest portfolios of healthcare information, therapeutic, domain, regulatory and commercial analytic expertise, as well as proprietary technology applications. IMS Health’s information solutions will be combined with Quintiles’ product development skills, and the business will provide a portfolio of anonymous patient records, technology-enabled data collection and observational research experts to address healthcare issues. The firms say they expect annual cost savings of $100m by the end of year three.
For the full story read MRWeb